Essure was a permanent birth control device manufactured by Bayer and marketed as a non-surgical alternative to tubal ligation. However, thousands of women reported serious health complications, including chronic pain, autoimmune reactions, and device migration. These reports led to significant public concern and legal action.
In August 2020, Bayer agreed to a $1.6 billion settlement to resolve the majority of U.S. lawsuits filed by women who alleged they were harmed by Essure. Although Bayer discontinued sales of Essure in 2018, the device was never officially recalled.
Marketed as a safer alternative to tubal ligation, Essure consisted of metal coils inserted into the fallopian tubes to trigger scar tissue and block fertilization. But instead of delivering reliable contraception, it exposed many women to dangerous and irreversible side effects.
The device remained on the market for over 15 years despite growing complaints. By the time Bayer discontinued Essure in 2018, the FDA had received tens of thousands of adverse event reports, including device migration, organ damage, and autoimmune responses. These event reports lead Bayer to halt sales in the United States.
If you or a loved one has been injured, don’t wait to seek legal help.
Call (800) 675-8556 or contact us online to get started.
These complications often left women physically debilitated and emotionally overwhelmed, especially after trusting that Essure would be a safe, permanent solution.
Essure lawsuits alleged that Bayer:
By prioritizing profits over patient safety, Bayer was held accountable under mass tort litigation.